Toggle navigation
Home
Search
Services
Blog
Contact
About
Heregulin (GP30) Expression and Drug Resistance
Lupu, Ruth
Lawrence Berkeley National Laboratory, Berkeley, CA, United States
Search 34 grants from Ruth Lupu
Search grants from Lawrence Berkeley National Laboratory
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Nitrite based neuroprotection after cardiac arrest
Effects/Ethanol/Specific sites/AMPA glutamate receptors
Genetics of Insulin & Resistance in Polycystic Ovary Syndrome
Biomedical Research Support
NMR Studies of Ras Oncogene Product P21
Recently added grants:
Radiation and checkpoint blockade for cancer immune therapy
Core A: Administration
Core B: Small Animal Radiation Core
Core C: Immune bioinformatics and biostatistics
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
7R21CA067242-02
Application #
2110874
Study Section
Special Emphasis Panel (ZRG3-ET-2 (02))
Project Start
1995-06-01
Project End
1998-01-31
Budget Start
1996-07-01
Budget End
1998-01-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Lawrence Berkeley National Laboratory
Department
Biology
Type
Organized Research Units
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Related projects
NIH 1996
R21 CA
Heregulin (GP30) Expression and Drug Resistance
Lupu, Ruth / Lawrence Berkeley National Laboratory
NIH 1995
R21 CA
Heregulin (GP30) Expression and Drug Resistance
Lupu, Ruth / Georgetown University
Comments
Be the first to comment on this grant